Literature DB >> 4465103

Immune manipulation by BCG administered before or after cyclophosphamide for chemo-immunotherapy of L1210 leukaemia.

G Mathé, O Halle-Pannenko, C Bourut.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4465103     DOI： 10.1016/0014-2964(74)90005-x

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0014-2964            Impact factor:   9.162


× No keyword cloud information.
  10 in total

1.  Successful chemoimmunotherapy of murine L1210 lymphatic leukemia with cyclophosphamide and mafosfamide-treated leukemia cells.

Authors:  M Kawalec; T Skórski; J Kawiak
Journal:  Invest New Drugs       Date:  1988-09       Impact factor: 3.850

2.  Immunotherapeutic agents: their role in cellular immunity and their therapeutic potential.

Authors:  M A Chirigos; J E Talmadge
Journal:  Springer Semin Immunopathol       Date:  1985

3.  Mycobacterium bovis, BCG, modulation of murine antibody responses: influence of dose and degree of aggregation of live or dead organisms.

Authors:  C A Brown; I N Brown
Journal:  Br J Exp Pathol       Date:  1982-04

4.  Augmentation of antitumor resistance by a strain of unicellular green algae, Chlorella vulgaris.

Authors:  K Tanaka; F Konishi; K Himeno; K Taniguchi; K Nomoto
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

5.  The role of the peritoneal cavity in successful treatment of a murine lymphoma with chemotherapy and non-specific immunostimulation.

Authors:  P Marconi; F Bistoni; A Cassone; L Frati; M Baccarini; E Garaci; E Bonmassar
Journal:  Cancer Immunol Immunother       Date:  1982       Impact factor: 6.968

6.  Therapeutic studies with BCG, cyclophosphamide and surgery alone and in combination on the autochthonous mammary carcinoma of the rat.

Authors:  E Storch; H H Fiebig; D Schmähl
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1977-05-20

7.  Further observations on the effect of cyclophosphamide on intratumor and peripheral leukocyte levels.

Authors:  R Evans
Journal:  Am J Pathol       Date:  1980-06       Impact factor: 4.307

8.  Effect of intralesional and systemic BCG-application or a combined cyclophosphamide/BCG treatment on experimental bladder cancer.

Authors:  H D Adolphs; J Thiele; H Kiel
Journal:  Urol Res       Date:  1979-06-22

Review 9.  Modulation of the immune response by BCG: a review.

Authors:  R I Murahata; M S Mitchell
Journal:  Yale J Biol Med       Date:  1976-07

10.  Possible role of macrophage-like suppressor cells in the anti-tumour activity of BCG.

Authors:  M Castés; N R Lynch; G Lespinats; S Orbach-Arbouys
Journal:  Br J Cancer       Date:  1981-12       Impact factor: 7.640
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.